G. C. Chemie Pharmie Ltd. We are an ambitious Indian pharmaceutical, Functional Food & Nutraceuticals company; partners with its principals & clients alike to deliver customized solutions that resolve their significant issues and create lasting competitive advantage. Utilizing decades of industry experience and functional expertise, we look beyond standard solutions to develop new insights, mobilize resources, drive tangible results, and make our partner more capable of meeting challenges in the burgeoning Indian pharmaceutical & Nutraceutical market. Our company, one of the first companies to realize the need of providing best and fast services to the pharmaceutical & nutraceuticals industries went on to become one of the top sales, Marketing & distribution company in India. It is one of the major suppliers of Pharmaceutical ingredients, Nutraceuticals, Basic Intermediates, Vitamins and Finished Formulations to its clients in India and around the globe. GCCPL has crossed yet another milestone of achieving $ 50 Million (USD) turn over in the year 2009-10 in spite of turbulent market conditions. Our growth has been fueled by its deep and wide penetration in to the vast Indian Pharmaceutical market and strong understanding of its challenges. It has 450 plus clients spread across the country and more than 50 across the globe. We believe in building ever lasting, rewarding relationship with its employees and clients alike that has strong foundation on higher standard of quality, trust, reliability and transparency in the conduct of the business, which leads to mutual growth. This is precisely the reason why GCCPL has grown many fold in three decades. In the last four years we looked beyond the conventional business growth and further plans for business expansion; established new strategic vertical business units to cater to specific needs of the clients. These vertical units include manufacturing of API, Marketing of finished formulations and in / out Licensing. In /Out Licensing division will specifically focus on identifying newer technology driven areas in existing segments or upcoming opportunities in the newer therapeutics.